Identification of Biomarkers in Follicular Lymphoma

Trial Profile

Identification of Biomarkers in Follicular Lymphoma

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2017

At a glance

  • Drugs Rituximab (Primary) ; Cyclophosphamide; Fludarabine; Prednisone; Vincristine
  • Indications Chronic lymphocytic leukaemia; Follicular lymphoma; Non-Hodgkin's lymphoma
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 17 May 2017 Status changed from active, no longer recruiting to completed.
    • 14 Jul 2016 New trial record
    • 21 Jun 2011 Status changed to active no longer recruiting as per ClinicalTrials.gov recors
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top